Suppr超能文献

日本早期乳腺癌保乳手术患者术后省略放疗的可行性

The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving Surgery.

作者信息

Nakashima Akihiro, Yamazaki Hideya, Suzuki Gen, Yamada Kei, Aibe Norihiro, Kimoto Takuya, Masui Koji, Nakatsukasa Katsuhiko, Taguchi Tetsuya, Naoi Yasuto

机构信息

Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.

Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JPN.

出版信息

Cureus. 2024 May 13;16(5):e60228. doi: 10.7759/cureus.60228. eCollection 2024 May.

Abstract

Background This study was aimed at analyzing the impact of postoperative radiotherapy (PORT) after breast-conserving surgery (BCS) on Japanese patients with early-stage breast cancer and exploring the potential of PORT omission. Materials and methods Data from 794 patients with early-stage breast cancer (T1-2, N0-1), who underwent BCS with (n = 310) or without PORT (n = 484) were retrospectively analyzed. Local control (LC) rate and breast cancer-specific survival (BCSS) were compared between the groups that received and did not receive PORT in the whole cohort and low-risk cohort (i.e., the cohort with negative surgical margin, lymph node negativity, and estrogen receptor positivity, excluding young age of 49 or less), and in low-risk subgroup using propensity-score matching. Results PORT was associated with better LC but not BCSS in the total population. In the low-risk cohort, the incidence of local recurrence in patients without and with PORT was 5.3% and 4.8%, respectively, at 10 years (p = 0.591), and 7.8% and 4.8%, respectively, according to propensity-score matching (p = 0.485). Conclusion PORT improved LC in the total population, but not BCSS or overall survival (OS). In the low-risk group analysis (negative surgical margin, lymph node negativity, estrogen receptor positivity, and age 50 years or more), equivalent LC, BCSS, and OS were found including propensity-matched comparison. Therefore, this study showed that the omission of PORT could be a treatment option for low-risk Japanese patients. Further multi-center prospective studies are warranted to validate these findings and reduce the unnecessary burden of PORT for patients and institutions.

摘要

背景 本研究旨在分析保乳手术(BCS)后术后放疗(PORT)对日本早期乳腺癌患者的影响,并探讨省略PORT的可能性。材料与方法 回顾性分析794例早期乳腺癌(T1-2,N0-1)患者的数据,这些患者接受了有(n = 310)或没有PORT(n = 484)的BCS。在整个队列和低风险队列(即手术切缘阴性、淋巴结阴性且雌激素受体阳性的队列,不包括49岁及以下的年轻患者)中,以及在使用倾向评分匹配的低风险亚组中,比较接受和未接受PORT的组之间的局部控制(LC)率和乳腺癌特异性生存(BCSS)。结果 在总人群中,PORT与更好的LC相关,但与BCSS无关。在低风险队列中,未接受PORT和接受PORT的患者10年局部复发率分别为5.3%和4.8%(p = 0.591),根据倾向评分匹配分别为7.8%和4.8%(p = 0.485)。结论 PORT改善了总人群的LC,但未改善BCSS或总生存(OS)。在低风险组分析(手术切缘阴性、淋巴结阴性、雌激素受体阳性且年龄50岁及以上)中,包括倾向匹配比较在内,发现LC、BCSS和OS相当。因此,本研究表明,省略PORT可能是低风险日本患者的一种治疗选择。有必要进行进一步的多中心前瞻性研究来验证这些发现,并减轻患者和机构不必要的PORT负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db1/11168898/44c543c00cf6/cureus-0016-00000060228-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验